Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices
May 16, 2023
Amsterdam, the Netherlands – RoyalPhilips (NYSE: PHG; AEX: PHIA), today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to assess potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall notification/field safety notice.*
The risk assessments have now been completed for the CPAP/BiPAP sleep therapy devices under the recall notification/field safety notice* i.e., the first-generation DreamStation, System One and DreamStation Go devices, representing approximately 95% of the registered devices globally. The assessments build on the previous updates in December 2021, June 2022, and December 2022. Additionally, tests and analyses have been completed for first-generation DreamStation devices that have been exposed to ozone cleaning.
The test and research program has been conducted together with five independent, certified testing laboratories, and the results have been reviewed and assessed by third-party qualified experts and Philips Respironics, as well as an external medical panel.
Philips Respironics has provided the summary of the completed set of test results and analyses for the CPAP/BiPAP sleep therapy devices to the FDA and other competent authorities. The FDA is still considering the data and analyses that Philips Respironics has provided and may reach a different conclusion.
The full press release is available here.
* Voluntary recall notification in the US/field safety notice for the rest of the world.
For media questions, please contact:
Philips Global Press Office
Tel.: +31 6 10888824
Elco van Groningen
Philips Global Press Office
Tel.: +31 6 81039584
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
This statement contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Results of additional issuance - RIKB 28 111530.5.2023 17:31:00 CEST | Press release
As stated in paragraph 6 in General Terms of Auction for Treasury bonds, the Government Debt Management offered the equivalent of 10% of the nominal value sold in the auction 26. May, at the price of accepted bids. SeriesRIKB 28 1115ISINIS0000028249Additional issuance (nominal)29,000,000Settlement date05/31/2023Total outstanding (nominal)103,350,801,519
Vaisala Oyj: SHARE REPURCHASE 30.5.202330.5.2023 17:30:00 CEST | Press release
VAISALA CORPORATIONSTOCK EXCHANGE RELEASE 30.5.2023VAISALA CORPORATION: SHARE REPURCHASE 30.5.2023In the Helsinki Stock ExchangeTrade date 30.5.2023Bourse trade BuyShare VAIASAmount 1 500SharesAverage price/ share 42,6096EURTotal cost 63 914,40EURVaisala Corporation now holds a total of 166 616 sharesincluding the shares repurchased on 30.5.2023On behalf of Vaisala CorporationNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information Paula Liimattatel +358 9 8949 2020, email@example.com Vaisala is a global leader in weather, environmental, and industrial measurements. Building on over 85 years of experience, Vaisala provides observations for a better world, with space-proof technology even exploring Mars and beyond. We are a reliable partner for customers around the world, offering a comprehensive range of innovative observation and measurement products and services. Headquartered in Finland, Vaisala employs over 2,000 professionals worldwide and is listed on t
Enento Group Plc: SHARE REPURCHASE 30.5.202330.5.2023 17:30:00 CEST | Press release
Enento Group PlcANNOUNCEMENT 30.5.2023Enento Group Plc: SHARE REPURCHASE 30.5.2023In the Helsinki Stock ExchangeTrade date30.5.2023Bourse tradeBuyShareENENTOAmount5,000SharesAverage price/ share18.9042EURTotal cost94,521.00EUREnento Group Plc now holds a total of 126 200 sharesincluding the shares repurchased on 30.5.2023On behalf of Enento Group PlcNordea Bank OyjJanne SarvikiviSami HuttunenFor further information:Arto PaukkuInvestor Relations Officertel. +358 50 469 5380www.enento.com Attachment Enento 30.5 trades
BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments30.5.2023 17:27:34 CEST | Press release
May 30, 2023 Announcement no. 10 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE, OR A SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES IN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE “UNITED STATES”)) OR ANY OTHER JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR WITH ANY SECURITIES REGULATORY AUTHORITY UNDER ANY APPLICABLE SECURITIES LAWS OF
Cortus Energy testlevererar syngas till bandugn hos Höganäs AB30.5.2023 17:15:28 CEST | Pressemelding
Cortus har de senaste två veckorna på dagtid levererat syngas till Höganäs bandugn för intrimning av brännarsystem inför kommande driftprover. Intrimningen har gått bra och följs upp med drift och utbildning av driftspersonal under de kommande veckorna. Testleveransen av syngas till en av Höganäs bandugnar är det första steget i att ersätta fossil naturgas med syngas i Höganäs AB:s produktion inom ramen för det samarbete som startades för sex år sedan mellan Cortus och Höganäs. När utbildning av driftspersonal är klar och produktionen är redo kan dagtidstesterna övergå i långtidstester och förhoppningsvis kontinuerliga syngasleveranser. Om allt går som planerat kan det här påbörjas under andra halvan av augusti i år. ”Detta är en glädjens dag för oss på Cortus och en belöning efter alla de vedermödor som varit kring vår WoodRoll® -anläggning. Vi vill också uttrycka vår tacksamhet till alla på Höganäs AB för deras stora tålamod”, säger Rolf Ljunggren, grundare och t f VD i Cortus Energy